Health Condition 1: L209- Atopic dermatitis, unspecified
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: clinically diagnosed patients eczema based on EASI scale , both sex , between age of 15-55 , willing and able to give written informed consent
Exclusion criteria
Exclusion criteria: Pt suffering from another skin diseases like psoriasis , lichen planus , tinea , bacterial and viral infections Autoimmune markers positive suggests lupus or other autoimmune skin conditions. Presence of systemic symptoms (like fever, weight loss) might indicate more serious conditions. Participants in another intervational study within the last 3 months. Presence of serious comorbidities (eg. Malignancy , uncontrolled diabetes , severe cardiac disease. pregnant or lactating women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in Eczema Area and Severity Index score from baseline to the end of the treatment. This measures the effectiveness of constitutional homeopathic medicine in reducing eczema severity.Timepoint: Change in Eczema Area and Severity Index score from baseline to the end of the treatment. This measures the effectiveness of constitutional homeopathic medicine in reducing eczema severity. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Improvement in patient-reported symptoms using a Visual Analog Scale 2. Improvement in quality of life assessed by Dermatology Life Quality Index or similar questionnaire. 3. Safety and tolerability of constitutional homeopathic medicineTimepoint: At 4 weeks, 8 weeks, and 12 weeks | — |
Countries
India
Contacts
RAJKOT HOMEOPATHIC MEDICAL COLLEGE